RRM1 and non-small cell lung carcinoma: In addition, we found that there was a significant association between the polymorphisms of RRM1 ‐585T>G and NSCLC with an adjusted OR of 0.62 (95% CI, 0.36–1.05; P = 0.07) by dominant models in patients with non–small‐cell lung cancer.